EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Delphine Sophie CourvoisierKim LauperJoanna KedraMaarten P T de WitBruno FautrelThomas FrisellKimmie L HyrichFlorenzo IannonePedro M MachadoLykke Midtbøll ØrnbjergŽiga RotarMaria Jose SantosTanja Alexandra StammSimon R StonesAnja StrangfeldSytske Anne BergstraRobert B M LandeweAxel FinckhPublished in: Annals of the rheumatic diseases (2022)
To improve the reliability of an increasing number of real-world comparative effectiveness studies in rheumatology, special attention is required to reduce potential biases. Adherence to clear recommendations for the analysis and reporting of observational comparative effectiveness studies will improve the trustworthiness of their results.